Search

everythinglearnresearchcommunity

for

Search:↓

Fetal environments contain various chemicals that may disrupt hormones.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride doesn't change rat testicle weight or sperm production.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

c-Kit is important for heart regeneration and cancer development.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Finasteride negatively affects fish reproduction and gonadal development.

Balding and low testosterone increase risk of urinary stones.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

A small BOTOX dose improved sperm production and movement in older mice.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.